Rafferty Asset Management, LLC Rubius Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

  • $26.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$4.25 - $10.4 $508,593 - $1.24 Million
-119,669 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$9.68 - $17.74 $324,938 - $595,496
33,568 Added 38.99%
119,669 $1.16 Million
Q3 2021

Nov 10, 2021
SELL
$17.6 - $25.91 $148,068 - $217,980
-8,413 Reduced 8.9%
86,101 $1.54 Million
Q2 2021

Aug 10, 2021
BUY
$22.26 - $28.43 $2.1 Million - $2.69 Million
94,514 New
94,514 $2.31 Million

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email